Home/Filings/4/0001437749-23-027433
4//SEC Filing

Xu Xiaochun 4

Accession 0001437749-23-027433

CIK 0000811212other

Filed

Oct 1, 8:00 PM ET

Accepted

Oct 2, 8:33 PM ET

Size

9.0 KB

Accession

0001437749-23-027433

Insider Transaction Report

Form 4
Period: 2023-09-28
Transactions
  • Conversion

    Common Stock

    2023-09-28$1.07/sh+654,206$700,000927,121 total(indirect: Held by Boyalife Group, Inc.)
  • Conversion

    Amendment 3 to 1st Amended & Restated Revolving Credit Agr.

    2023-09-28(indirect: Held by Boyalife Group, Inc.)
    Exercise: $1.07From: 2018-04-16Exp: 2023-12-31Common Stock (654,206 underlying)
Xu Xiaochun
Director
Transactions
  • Conversion

    Common Stock

    2023-09-28$1.07/sh+654,206$700,000927,121 total(indirect: Held by Boyalife Group, Inc.)
  • Conversion

    Amendment 3 to 1st Amended & Restated Revolving Credit Agr.

    2023-09-28(indirect: Held by Boyalife Group, Inc.)
    Exercise: $1.07From: 2018-04-16Exp: 2023-12-31Common Stock (654,206 underlying)
Footnotes (1)
  • [F1]On September 28, 2023, Boyalife Group, Inc. converted an aggregate of $700,000 of outstanding interest under a Second Amended and Restated Convertible Promissory Note issued by Issuer in April 2018, as amended. After giving effect to the conversion, as of the date of this Form 4, there was $7,278,000 in principal and approximately $216,000 in accrued interest outstanding under the Convertible Promissory Note, all of which is convertible at a current conversion price of $1.07 per share, subject to downward adjustment in the event that the Issuer issues shares of common stock at a lower price. Boyalife Group, Inc. is 100% owned by Dr. Xiaochun Xu.

Issuer

ThermoGenesis Holdings, Inc.

CIK 0000811212

Entity typeother

Related Parties

1
  • filerCIK 0001669192

Filing Metadata

Form type
4
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 8:33 PM ET
Size
9.0 KB